Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?
Jacobus Adrianus Burgers, Ronald Alphons Damhuis
ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jacobus Adrianus Burgers, Ronald Alphons Damhuis. 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?. ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
The impact of anti-IgE treatment on the airway microbiome in asthma.